Copyright Reports & Markets. All rights reserved.

Global HIV Vaccines Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of HIV Vaccines

      • 1.1 Definition of HIV Vaccines
      • 1.2 HIV Vaccines Segment by Type
        • 1.2.1 Global HIV Vaccines Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Phase I
        • 1.2.3 Phase II
        • 1.2.4 Phase III
      • 1.3 HIV Vaccines Segment by Applications
        • 1.3.1 Global HIV Vaccines Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Research Institute
        • 1.3.3 Other
      • 1.4 Global HIV Vaccines Overall Market
        • 1.4.1 Global HIV Vaccines Revenue (2014-2025)
        • 1.4.2 Global HIV Vaccines Production (2014-2025)
        • 1.4.3 North America HIV Vaccines Status and Prospect (2014-2025)
        • 1.4.4 Europe HIV Vaccines Status and Prospect (2014-2025)
        • 1.4.5 China HIV Vaccines Status and Prospect (2014-2025)
        • 1.4.6 Japan HIV Vaccines Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia HIV Vaccines Status and Prospect (2014-2025)
        • 1.4.8 India HIV Vaccines Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of HIV Vaccines
      • 2.3 Manufacturing Process Analysis of HIV Vaccines
      • 2.4 Industry Chain Structure of HIV Vaccines

      3 Development and Manufacturing Plants Analysis of HIV Vaccines

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global HIV Vaccines Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of HIV Vaccines
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 HIV Vaccines Production and Capacity Analysis
      • 4.2 HIV Vaccines Revenue Analysis
      • 4.3 HIV Vaccines Price Analysis
      • 4.4 Market Concentration Degree

      5 HIV Vaccines Regional Market Analysis

      • 5.1 HIV Vaccines Production by Regions
        • 5.1.1 Global HIV Vaccines Production by Regions
        • 5.1.2 Global HIV Vaccines Revenue by Regions
      • 5.2 HIV Vaccines Consumption by Regions
      • 5.3 North America HIV Vaccines Market Analysis
        • 5.3.1 North America HIV Vaccines Production
        • 5.3.2 North America HIV Vaccines Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America HIV Vaccines Import and Export
      • 5.4 Europe HIV Vaccines Market Analysis
        • 5.4.1 Europe HIV Vaccines Production
        • 5.4.2 Europe HIV Vaccines Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe HIV Vaccines Import and Export
      • 5.5 China HIV Vaccines Market Analysis
        • 5.5.1 China HIV Vaccines Production
        • 5.5.2 China HIV Vaccines Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China HIV Vaccines Import and Export
      • 5.6 Japan HIV Vaccines Market Analysis
        • 5.6.1 Japan HIV Vaccines Production
        • 5.6.2 Japan HIV Vaccines Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan HIV Vaccines Import and Export
      • 5.7 Southeast Asia HIV Vaccines Market Analysis
        • 5.7.1 Southeast Asia HIV Vaccines Production
        • 5.7.2 Southeast Asia HIV Vaccines Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia HIV Vaccines Import and Export
      • 5.8 India HIV Vaccines Market Analysis
        • 5.8.1 India HIV Vaccines Production
        • 5.8.2 India HIV Vaccines Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India HIV Vaccines Import and Export

      6 HIV Vaccines Segment Market Analysis (by Type)

      • 6.1 Global HIV Vaccines Production by Type
      • 6.2 Global HIV Vaccines Revenue by Type
      • 6.3 HIV Vaccines Price by Type

      7 HIV Vaccines Segment Market Analysis (by Application)

      • 7.1 Global HIV Vaccines Consumption by Application
      • 7.2 Global HIV Vaccines Consumption Market Share by Application (2014-2019)

      8 HIV Vaccines Major Manufacturers Analysis

      • 8.1 Argos Therapeutics
        • 8.1.1 Argos Therapeutics HIV Vaccines Production Sites and Area Served
        • 8.1.2 Argos Therapeutics Product Introduction, Application and Specification
        • 8.1.3 Argos Therapeutics HIV Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Bionor Pharma
        • 8.2.1 Bionor Pharma HIV Vaccines Production Sites and Area Served
        • 8.2.2 Bionor Pharma Product Introduction, Application and Specification
        • 8.2.3 Bionor Pharma HIV Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Janssen Global Services
        • 8.3.1 Janssen Global Services HIV Vaccines Production Sites and Area Served
        • 8.3.2 Janssen Global Services Product Introduction, Application and Specification
        • 8.3.3 Janssen Global Services HIV Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Genecure
        • 8.4.1 Genecure HIV Vaccines Production Sites and Area Served
        • 8.4.2 Genecure Product Introduction, Application and Specification
        • 8.4.3 Genecure HIV Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Geovax,
        • 8.5.1 Geovax, HIV Vaccines Production Sites and Area Served
        • 8.5.2 Geovax, Product Introduction, Application and Specification
        • 8.5.3 Geovax, HIV Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Paxvax Corporation
        • 8.6.1 Paxvax Corporation HIV Vaccines Production Sites and Area Served
        • 8.6.2 Paxvax Corporation Product Introduction, Application and Specification
        • 8.6.3 Paxvax Corporation HIV Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Inovio Pharmaceuticals
        • 8.7.1 Inovio Pharmaceuticals HIV Vaccines Production Sites and Area Served
        • 8.7.2 Inovio Pharmaceuticals Product Introduction, Application and Specification
        • 8.7.3 Inovio Pharmaceuticals HIV Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Glaxosmithkline
        • 8.8.1 Glaxosmithkline HIV Vaccines Production Sites and Area Served
        • 8.8.2 Glaxosmithkline Product Introduction, Application and Specification
        • 8.8.3 Glaxosmithkline HIV Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Sanofi
        • 8.9.1 Sanofi HIV Vaccines Production Sites and Area Served
        • 8.9.2 Sanofi Product Introduction, Application and Specification
        • 8.9.3 Sanofi HIV Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served

      9 Development Trend of Analysis of HIV Vaccines Market

      • 9.1 Global HIV Vaccines Market Trend Analysis
        • 9.1.1 Global HIV Vaccines Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 HIV Vaccines Regional Market Trend
        • 9.2.1 North America HIV Vaccines Forecast 2019-2025
        • 9.2.2 Europe HIV Vaccines Forecast 2019-2025
        • 9.2.3 China HIV Vaccines Forecast 2019-2025
        • 9.2.4 Japan HIV Vaccines Forecast 2019-2025
        • 9.2.5 Southeast Asia HIV Vaccines Forecast 2019-2025
        • 9.2.6 India HIV Vaccines Forecast 2019-2025
      • 9.3 HIV Vaccines Market Trend (Product Type)
      • 9.4 HIV Vaccines Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 HIV Vaccines Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        HIV Vaccine Market has been segmented on the basis of type which comprises of acute paronychia, chronic paronychia, candidal paronychia and pyogenic paronychia. On the basis of antibiotics, market is segmented into mupirocin ointment, fusidic acid ointment, gentamicin ointment, dicloxacillin and others.
        Globally North America is the largest market for HIV vaccine market. The large size of the market can be attributed to higher adoption of various HIV vaccine trials coupled with presence of technologically and advancement.

        The global HIV Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on HIV Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall HIV Vaccines market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of HIV Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their HIV Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Argos Therapeutics
        Bionor Pharma
        Janssen Global Services
        Genecure
        Geovax,
        Paxvax Corporation
        Inovio Pharmaceuticals
        Glaxosmithkline
        Sanofi

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Phase I
        Phase II
        Phase III

        Segment by Application
        Research Institute
        Other

        Buy now